455 related articles for article (PubMed ID: 31638225)
41. A 9‑lncRNA risk score system for predicting the prognosis of patients with hepatitis B virus‑positive hepatocellular carcinoma.
Liu H; Zhao P; Jin X; Zhao Y; Chen Y; Yan T; Wang J; Wu L; Sun Y
Mol Med Rep; 2019 Jul; 20(1):573-583. PubMed ID: 31115573
[TBL] [Abstract][Full Text] [Related]
42. Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity.
Feng C; Shen JM; Lv PP; Jin M; Wang LQ; Rao JP; Feng L
Int J Biol Sci; 2018; 14(10):1361-1377. PubMed ID: 30123082
[TBL] [Abstract][Full Text] [Related]
43. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
44. Five lncRNAs associated with the survival of hepatocellular carcinoma: a comprehensive study based on WGCNA and competing endogenous RNA network.
Liu DH; Wang SL; Hua Y; Shi GD; Qiao JH; Wei H
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7621-7633. PubMed ID: 32744688
[TBL] [Abstract][Full Text] [Related]
45. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
[TBL] [Abstract][Full Text] [Related]
46. Integrative Analysis of ceRNA Network Reveals Functional lncRNAs in Intrahepatic Cholangiocarcinoma.
Zhou D; Gao B; Yang Q; Kong Y; Wang W
Biomed Res Int; 2019; 2019():2601271. PubMed ID: 31886187
[TBL] [Abstract][Full Text] [Related]
47. Integrated analysis of ceRNA network in hepatocellular carcinoma using bioinformatics analysis.
Luo Y; Li H; Huang H; Xue L; Li H; Liu L; Fu H
Medicine (Baltimore); 2021 Jun; 100(22):e26194. PubMed ID: 34087888
[TBL] [Abstract][Full Text] [Related]
48. LINC01018 and SMIM25 sponged miR-182-5p in endometriosis revealed by the ceRNA network construction.
Jiang L; Zhang M; Wang S; Xiao Y; Wu J; Zhou Y; Fang X
Int J Immunopathol Pharmacol; 2020; 34():2058738420976309. PubMed ID: 33237828
[TBL] [Abstract][Full Text] [Related]
49. Potential lncRNA Biomarkers for HBV-Related Hepatocellular Carcinoma Diagnosis Revealed by Analysis on Coexpression Network.
Nong S; Chen X; Wang Z; Xu G; Wei W; Peng B; Zhou L; Wei L; Zhao J; Wei Q; Deng Y; Meng L
Biomed Res Int; 2021; 2021():9972011. PubMed ID: 34692847
[TBL] [Abstract][Full Text] [Related]
50. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
51. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
Wang B; Tang D; Zhang Z; Wang Z
J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
[TBL] [Abstract][Full Text] [Related]
52. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
53. Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells.
Lv J; Fan HX; Zhao XP; Lv P; Fan JY; Zhang Y; Liu M; Tang H
Cancer Lett; 2016 Nov; 382(2):166-175. PubMed ID: 27597739
[TBL] [Abstract][Full Text] [Related]
54. lncRNA TMEM51-AS1 and RUSC1-AS1 function as ceRNAs for induction of laryngeal squamous cell carcinoma and prediction of prognosis.
Hui L; Wang J; Zhang J; Long J
PeerJ; 2019; 7():e7456. PubMed ID: 31565549
[TBL] [Abstract][Full Text] [Related]
55. Construction of a disease-specific lncRNA-miRNA-mRNA regulatory network reveals potential regulatory axes and prognostic biomarkers for hepatocellular carcinoma.
Zhang Q; Sun L; Zhang Q; Zhang W; Tian W; Liu M; Wang Y
Cancer Med; 2020 Dec; 9(24):9219-9235. PubMed ID: 33232580
[TBL] [Abstract][Full Text] [Related]
56. ceRNA network development and tumor-infiltrating immune cell analysis in hepatocellular carcinoma.
Chen L; Zou W; Zhang L; Shi H; Li Z; Ni C
Med Oncol; 2021 Jun; 38(7):85. PubMed ID: 34148185
[TBL] [Abstract][Full Text] [Related]
57. Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.
Wang XW; Guo QQ; Wei Y; Ren KM; Zheng FS; Tang J; Zhang HY; Zhao JG
Oncol Rep; 2019 Dec; 42(6):2402-2415. PubMed ID: 31638248
[TBL] [Abstract][Full Text] [Related]
58. Upregulated lncRNA Pvt1 may be important for cardiac remodeling at the infarct border zone.
Liu B; Cheng Y; Tian J; Zhang L; Cui X
Mol Med Rep; 2020 Oct; 22(4):2605-2616. PubMed ID: 32945428
[TBL] [Abstract][Full Text] [Related]
59. Competing endogenous RNA network and prognostic nomograms for hepatocellular carcinoma patients who underwent R0 resection.
Li Y; Ma B; Yin Z; Liu P; Liu J; Li J; Wang F; Chen H
J Cell Physiol; 2019 Nov; 234(11):20342-20353. PubMed ID: 30963571
[TBL] [Abstract][Full Text] [Related]
60. Comprehensive analysis of differentially expressed profiles and reconstruction of a competing endogenous RNA network in papillary renal cell carcinoma.
Luo Q; Cui M; Deng Q; Liu J
Mol Med Rep; 2019 Jun; 19(6):4685-4696. PubMed ID: 30957192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
